Willem Martin Smid (W Martin Smid, Martin Smid, W Martin Smid)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Liquid Chromatography

Respiratory Syndrome Coronavirus

Candida Albicans

Quality Control

Top Venues

UMCG

This page only lists publications with an associated author ORCID identifier.

Affiliation History

UMCG Apr 01 2010

Netherlands

Staf Counsellor

Sanquin Apr 01 1996

Netherlands

Managing director :: Consulting Services

Publications

Thierry Burnouf, Jay Epstein, Jean-Claude Faber, Willem Martin Smid
Response to comments from the International Patient Organization for Primary Immunodeficiencies on 'Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low- and middle-income countries'. Vox sanguinis (2024)
Thierry Burnouf, Jay S Epstein, Jean-Claude Faber, Willem Martin Smid, null null
Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low- and middle-income countries. Vox sanguinis (2023)
Willem Martin Smid, Daphne C Thijssen-Timmer
Safeguarding plasma for fractionation: How can we deal with operational challenges in European Union countries. Vox sanguinis (2023)
Thierry Burnouf, Jay S Epstein, Jean-Claude Faber, Willem Martin Smid
Stepwise access to safe plasma proteins in resource-constrained countries: Local production and pathways to fractionation-Report of an International Society of Blood Transfusion Workshop. Vox sanguinis 117 (6) (2022)
Jay S Epstein, Willem Martin Smid, Silvano Wendel, Daniel Somuah, Thierry Burnouf
Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections. NPJ vaccines 5 (1) (2020)
Jay Epstein, Willem Martin Smid, Silvano Wendel, Daniel Somuah, Thierry Burnouf
Use of COVID-19 convalescent plasma in low- and middle-income countries: a call for ethical principles and the assurance of quality and safety. Vox sanguinis 116 (1) (2020)